CDNA vs MANE
CareDx, Inc vs Veradermics, Incorporated — AI-powered side-by-side comparison
VS
MANE
Veradermics, Incorporated
60
Buy
| Metric | CDNA | MANE |
|---|
| AI Score |
59
|
60
|
| Price |
$47.20
|
$108.67
|
| P/E Ratio |
21.95×
|
-69.84×
|
| ROE |
-7.0%
|
57.8%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
70.6%
|
0.0%
|
| Debt / Equity |
0.05×
|
0.00×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
74.3
|
47.9
|
| Beta |
2.419
|
1.3492
|
| Expected Upside |
—
|
—
|
AI Committee View
Current Innellis committee reasoning for CDNA versus MANE.
MANE leads by 1 points.
MANE scores 60/100 (Buy) versus CDNA at 59/100 (Buy).
CDNA Committee View
75% agreement
4 analysts
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — bollinger bandwidth of 50.3% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
- Trend and market structure agree -- coherent bullish picture — Technical
Bear Case
- RSI at 74 is in overbought territory — Technical
- Weekly RSI at 86 -- overbought on the larger timeframe too — Technical
- Bollinger bandwidth of 50.3% signals elevated volatility — Risk
MANE Committee View
50% agreement
4 analysts
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — bollinger bandwidth of 17.4% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
- Trend and market structure agree -- coherent bullish picture — Technical
Bear Case
- Bollinger bandwidth of 17.4% signals elevated volatility — Risk